SCHEMBL4659869

SCHEMBL4659869

COc1nc(C(=O)CF)c(NC(=O)OC(C)(C)C)cc1F

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 2/20 0.38
BRAF P15056 1/20 0.35
CFTR P13569 3/20 0.34
KCNQ4 P56696 1/20 0.34
KCNQ5 Q9NR82 1/20 0.34
SYK P43405 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
METAP1 P53582 1/20 0.33
P2RX3 P56373 1/20 0.33
AAK1 Q2M2I8 2/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
CACNA1H O95180 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNA1C Q13936 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
ATR Q13535 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137733 0.84 CFTR (0.33) CFTR
SCHEMBL3467391 0.80 ATR (0.41) CYP17A1BRAFKCNQ4KCNQ5SYK
SCHEMBL3466006 0.79 CYP17A1 (0.35) CYP17A1BRAFCFTRKCNQ4KCNQ5
SCHEMBL14783859 0.72 CFTR (0.44) CYP17A1CFTRRXFP1METAP1AAK1
SCHEMBL14784342 0.72 CFTR (0.49) CFTRRXFP1METAP1AAK1CACNA1H
SCHEMBL14725520 0.70 CYP17A1 (0.48) CYP17A1BRAFKCNQ4KCNQ5SYK
SCHEMBL3401775 0.70 CYP17A1 (0.41) CYP17A1BRAFKCNQ4KCNQ5RXFP1
SCHEMBL31662566 0.69 AAK1 (0.48) CYP17A1AAK1MTNR1AMTNR1B
SCHEMBL14923559 0.69 SYK (0.46) CYP17A1SYKATR
SCHEMBL5785487 0.69 AAK1 (0.48) CYP17A1AAK1MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2005995-A1 Heterocyclic compounds for the treatment of tuberculosis GLAXO GROUP LIMITED (GB) 2008-12-24 EP disclosed